Novel theranostic reagent could enhance detection and therapy of prostate cancer

(Society of Nuclear Medicine and Molecular Imaging) A novel nuclear medicine radiotracer could help identify the extent of metastatic prostate cancer and select patients for therapy. The study is featured in The Journal of Nuclear Medicine.